This week Pfizer is set to announce its financial backing of the development of an embryonic stem cell therapy to cure age-related macular degeneration (AMD). The clinical trial would begin in about two years.
Read about it here.
India Briefs: Recent Incidents of Persecution
2 hours ago
0 comments:
Post a Comment